Clinical trial
Pooled Individual Patient Survival Analysis of Early TNBC Women Treated With Dose Dense Sequential Adjuvant Chemotherapy in the Context of 7 Studies Conducted by the Hellenic Cooperative Oncology Group
NCT07820228 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pooled Individual Patient Survival Analysis of Early TNBC Women Treated With Dose Dense Sequential Adjuvant Chemotherapy in the Context of 7 Studies Conducted by the Hellenic Cooperative Oncology Group
- Lead sponsor
- Hellenic Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 10, 1996
- Completion date
- July 13, 2026
- Enrollment
- 3,648 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
triple negative breast cancer